{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T09:34:21Z","timestamp":1793093661165,"version":"4.5.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T00:00:00Z","timestamp":1688774400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021716","name":"Universit\u00e9 de Paris","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021716","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-17-RHUS-0009"],"award-info":[{"award-number":["ANR-17-RHUS-0009"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006489","name":"Commissariat \u00e0 l'\u00c9nergie Atomique et aux \u00c9nergies Alternatives","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006489","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jhepr.2023.100845","type":"journal-article","created":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T02:29:03Z","timestamp":1689128943000},"page":"100845","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["A new NRF2 activator for the treatment of human metabolic dysfunction-associated fatty liver disease"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6928-7431","authenticated-orcid":false,"given":"Adel","family":"Hammoutene","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Laouirem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7311-1623","authenticated-orcid":false,"given":"Miguel","family":"Albuquerque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Colnot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang\u00e9lique","family":"Brzustowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4460-7643","authenticated-orcid":false,"given":"Dominique","family":"Valla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Provost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8649-9724","authenticated-orcid":false,"given":"Philippe","family":"Delerive","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Paradis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2023.100845_bib1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(21)01701-3","article-title":"The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality","volume":"399","author":"Karlsen","year":"2022","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.jhepr.2023.100845_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100845_bib3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100845_bib4","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2023.100845_bib5","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.jhepr.2023.100845_bib6","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100845_bib7","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100845_bib8","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jhepr.2023.100845_bib9","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100845_bib10","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease \u2013 a global public health perspective","volume":"70","author":"Younossi","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100845_bib11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41575-020-00408-y","article-title":"Therapeutic pipeline in nonalcoholic steatohepatitis","volume":"18","author":"Vuppalanchi","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100845_bib12","doi-asserted-by":"crossref","first-page":"8082","DOI":"10.3748\/wjg.v20.i25.8082","article-title":"Oxidative stress as a crucial factor in liver diseases","volume":"20","author":"Cicho\u017c-Lach","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100845_bib13","article-title":"Role of oxidative stress in pathophysiology of nonalcoholic fatty liver disease","volume":"2018","author":"Masarone","year":"2018","journal-title":"Oxid Med Cel Longev"},{"key":"10.1016\/j.jhepr.2023.100845_bib14","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/01.mcg.0000212608.59090.08","article-title":"Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD)","volume":"40","author":"Madan","year":"2006","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100845_bib15","first-page":"3022","article-title":"Systemic oxidative\u00a0alterations are associated with visceral adiposity and liver steatosis in patients with metabolic syndrome","volume":"136","author":"Palmieri","year":"2006","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.jhepr.2023.100845_bib16","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.jhep.2020.09.037","article-title":"Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis","volume":"74","author":"Mohs","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100845_bib17","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1042\/CS20030285","article-title":"Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients","volume":"106","author":"Videla","year":"1979","journal-title":"Clin Sci Lond Engl"},{"key":"10.1016\/j.jhepr.2023.100845_bib18","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1146\/annurev-pharmtox-010818-021856","article-title":"Modulating NRF2 in disease: timing is everything","volume":"59","author":"Dodson","year":"2019","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.jhepr.2023.100845_bib19","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1128\/MCB.26.8.2887-2900.2006","article-title":"Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model","volume":"26","author":"Tong","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jhepr.2023.100845_bib20","doi-asserted-by":"crossref","first-page":"7511","DOI":"10.1128\/MCB.00753-07","article-title":"Different electrostatic potentials define ETGE and DLG motifs as hinge and latch in oxidative stress response","volume":"27","author":"Tong","year":"2007","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jhepr.2023.100845_bib21","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.bbamcr.2018.02.010","article-title":"Nrf2-Keap1 signaling in oxidative and reductive stress","volume":"1865","author":"Bellezza","year":"2018","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"10.1016\/j.jhepr.2023.100845_bib22","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tibs.2014.02.002","article-title":"The Nrf2 regulatory network provides an interface between redox and intermediary metabolism","volume":"39","author":"Hayes","year":"2014","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.jhepr.2023.100845_bib23","doi-asserted-by":"crossref","first-page":"13079","DOI":"10.3748\/wjg.v20.i36.13079","article-title":"Role of Nrf2 in chronic liver disease","volume":"20","author":"Tang","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100845_bib24","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.3389\/fphar.2018.01428","article-title":"The Role of Nrf2 in liver disease: novel molecular mechanisms and therapeutic approaches","volume":"9","author":"Xu","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jhepr.2023.100845_bib25","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1038\/s41467-018-04361-y","article-title":"The histone demethylase Phf2 acts as a molecular checkpoint to prevent NAFLD progression during obesity","volume":"9","author":"Bricambert","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhepr.2023.100845_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw9709","article-title":"Liver macrophages inhibit the endogenous antioxidant response in obesity-associated insulin resistance","volume":"12","author":"Azzimato","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jhepr.2023.100845_bib27","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1124\/jpet.107.135822","article-title":"NF-E2-related factor 2 inhibits lipid accumulation and oxidative stress in mice fed a high-fat diet","volume":"325","author":"Tanaka","year":"2008","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jhepr.2023.100845_bib28","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.freeradbiomed.2009.11.007","article-title":"Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitis","volume":"48","author":"Chowdhry","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jhepr.2023.100845_bib29","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1124\/mol.112.084269","article-title":"Nrf2 activators attenuate the progression of nonalcoholic steatohepatitis-related fibrosis in a dietary rat model","volume":"84","author":"Shimozono","year":"2013","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jhepr.2023.100845_bib30","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jcmgh.2017.11.016","article-title":"Experimental nonalcoholic steatohepatitis and liver fibrosis are ameliorated by pharmacologic activation of Nrf2 (NF-E2 p45-Related Factor 2)","volume":"5","author":"Sharma","year":"2018","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100845_bib31","doi-asserted-by":"crossref","first-page":"54750","DOI":"10.1074\/jbc.M410073200","article-title":"Crystal structure of the Kelch domain of human Keap1","volume":"279","author":"Li","year":"2004","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jhepr.2023.100845_bib32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ddtec.2017.10.001","article-title":"The Keap1-Nrf2 protein-protein interaction: a suitable target for small molecules","volume":"24","author":"Schmoll","year":"2017","journal-title":"Drug Discov Today Technol"},{"key":"10.1016\/j.jhepr.2023.100845_bib33","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1021\/acs.jmedchem.6b00228","article-title":"Monoacidic inhibitors of the Kelch-like ECH-associated protein 1: nuclear factor erythroid 2-related factor 2 (KEAP1:NRF2) protein-protein interaction with high cell potency identified by fragment-based discovery","volume":"59","author":"Davies","year":"2016","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.jhepr.2023.100845_bib34","article-title":"Selective disruption of NRF2-KEAP1 interaction leads to NASH resolution and reduction of liver fibrosis in mice","volume":"5","author":"Seedorf","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2023.100845_bib35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12072-018-9913-7","article-title":"Precision-cut liver slices: a versatile tool to advance liver research","volume":"13","author":"Palma","year":"2019","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhepr.2023.100845_bib36","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/hep.26461","article-title":"Hepatoprotective effects of the dual peroxisome proliferator-activated\u00a0receptor alpha\/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"58","author":"Staels","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100845_bib37","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1053\/j.gastro.2016.01.038","article-title":"Elafibranor, an agonist of the peroxisome proliferator-activated receptor-\u03b1 and -\u03b4, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening","volume":"150","author":"Ratziu","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2023.100845_bib38","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1111\/liv.14888","article-title":"Elafibranor and liraglutide improve differentially liver health and metabolism in a mouse model of non-alcoholic steatohepatitis","volume":"41","author":"Perakakis","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2023.100845_bib39","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/nprot.2010.111","article-title":"Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies","volume":"5","author":"de Graaf","year":"2010","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jhepr.2023.100845_bib40","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/hep.30651","article-title":"A\u00a0bioreactor technology for modeling fibrosis in human and rodent precision-cut liver slices","volume":"70","author":"Paish","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100845_bib41","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/hep.25738","article-title":"Efficient replication of primary or culture hepatitis C virus isolates in human liver slices: a relevant ex\u00a0vivo model of liver infection","volume":"56","author":"Lagaye","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100845_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.dib.2019.104093","article-title":"Transcriptomics data of a human in\u00a0vitro model of non-alcoholic steatohepatitis exposed to elafibranor","volume":"25","author":"Boeckmans","year":"2019","journal-title":"Data Brief"},{"key":"10.1016\/j.jhepr.2023.100845_bib43","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s00535-012-0739-0","article-title":"Increased hepatic oxidative DNA damage in patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma","volume":"48","author":"Tanaka","year":"2013","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100845_bib44","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1093\/oxfordjournals.bmb.a011637","article-title":"The importance of oxidative stress in apoptosis","volume":"53","author":"Clutton","year":"1997","journal-title":"Br Med Bull"},{"key":"10.1016\/j.jhepr.2023.100845_bib45","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/sj.cdd.4400938","article-title":"DNA damage and apoptosis","volume":"8","author":"Wang","year":"2001","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jhepr.2023.100845_bib46","article-title":"The role of cGAS-STING signalling in liver diseases","volume":"3","author":"Chen","year":"2021","journal-title":"JHEP Rep Innov Hepatol"},{"key":"10.1016\/j.jhepr.2023.100845_bib47","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1053\/j.gastro.2018.09.010","article-title":"Expression of STING is increased in liver tissues from patients with NAFLD and promotes macrophage-mediated hepatic inflammation and fibrosis in mice","volume":"155","author":"Luo","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2023.100845_bib48","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2337\/db07-1318","article-title":"Activation of peroxisome proliferator-activated receptor (PPAR)delta promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese men","volume":"57","author":"Ris\u00e9rus","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.jhepr.2023.100845_bib49","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jhep.2019.01.026","article-title":"Autophagy in liver diseases: time for translation?","volume":"70","author":"Allaire","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100845_bib50","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jhep.2019.10.028","article-title":"A\u00a0defect in endothelial autophagy occurs in patients with non-alcoholic steatohepatitis and promotes inflammation and fibrosis","volume":"72","author":"Hammoutene","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100845_bib51","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.3748\/wjg.v20.i7.1768","article-title":"Role of endoplasmic reticulum stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"20","author":"Zhang","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100845_bib52","doi-asserted-by":"crossref","first-page":"542","DOI":"10.4161\/auto.4600","article-title":"How to interpret LC3 immunoblotting","volume":"3","author":"Mizushima","year":"2007","journal-title":"Autophagy"},{"key":"10.1016\/j.jhepr.2023.100845_bib53","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.jhep.2019.02.012","article-title":"Role of liver sinusoidal endothelial cells in non-alcoholic fatty liver disease","volume":"70","author":"Hammoutene","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100845_bib54","doi-asserted-by":"crossref","first-page":"7137","DOI":"10.3390\/ijms22137137","article-title":"Best practices and progress in precision-cut liver slice cultures","volume":"22","author":"Dewyse","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhepr.2023.100845_bib55","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/hep.30626","article-title":"Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps","volume":"70","author":"Lonardo","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100845_bib56","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.2337\/dc22-2048","article-title":"High prevalence of NASH and advanced fibrosis in type 2 diabetes: a prospective study of 330 outpatients undergoing liver biopsies for elevated ALT, using a low threshold","volume":"46","author":"Castera","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jhepr.2023.100845_bib57","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1038\/s41598-021-83974-8","article-title":"Beneficial effects of elafibranor on NASH in E3L.CETP mice and differences between mice and men","volume":"11","author":"van den Hoek","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2023.100845_bib58","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/carcin\/bgp100","article-title":"Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice","volume":"30","author":"Yates","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jhepr.2023.100845_bib59","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/597134","article-title":"The dual role of Nrf2 in nonalcoholic fatty liver disease: regulation of antioxidant defenses and hepatic lipid metabolism","volume":"2015","author":"Chambel","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jhepr.2023.100845_bib60","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ccr.2006.12.016","article-title":"Deletion of NEMO\/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma","volume":"11","author":"Luedde","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jhepr.2023.100845_bib61","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/labinvest.2014.131","article-title":"Regulation of autophagy by protein post-translational modification","volume":"95","author":"Wani","year":"2015","journal-title":"Lab Investig J Tech Methods Pathol"},{"key":"10.1016\/j.jhepr.2023.100845_bib62","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1111\/jgh.13318","article-title":"Unique features associated with hepatic oxidative DNA damage and DNA methylation in non-alcoholic fatty liver disease","volume":"31","author":"Nishida","year":"2016","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100845_bib63","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.devcel.2022.06.003","article-title":"Replication stress triggered by nucleotide pool imbalance drives DNA damage and cGAS-STING pathway activation in NAFLD","volume":"57","author":"Donne","year":"2022","journal-title":"Dev Cell"},{"key":"10.1016\/j.jhepr.2023.100845_bib64","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1136\/gut.2004.053850","article-title":"Apoptosis: a mechanism of acute and chronic liver injury","volume":"54","author":"Guicciardi","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2023.100845_bib65","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/S0006-2952(03)00510-0","article-title":"DNA damage-triggered apoptosis: critical role of DNA repair, double-strand breaks, cell proliferation and signaling","volume":"66","author":"Kaina","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jhepr.2023.100845_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103335","article-title":"Myeloid Nrf2 deficiency\u00a0aggravates non-alcoholic steatohepatitis progression by regulating YAP-mediated NLRP3 inflammasome signaling","volume":"24","author":"Wang","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.jhepr.2023.100845_bib67","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1042\/BST20150014","article-title":"Dissecting molecular cross-talk between Nrf2 and NF-\u03baB response pathways","volume":"43","author":"Wardyn","year":"2015","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.jhepr.2023.100845_bib68","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3748\/wjg.v24.i2.179","article-title":"Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis","volume":"24","author":"T\u00f8lb\u00f8l","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100845_bib69","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.2337\/db11-0807","article-title":"Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy","volume":"60","author":"Zheng","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.jhepr.2023.100845_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201044","article-title":"Nrf2 protects stellate cells from Smad-dependent cell activation","volume":"13","author":"Prestigiacomo","year":"2018","journal-title":"PLoS One"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555923001763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555923001763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:09:37Z","timestamp":1778904577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555923001763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":70,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S2589555923001763"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2023.100845","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new NRF2 activator for the treatment of human metabolic dysfunction-associated fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2023.100845","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100845"}}